Literature DB >> 22826149

Declines in prostate cancer incidence after changes in screening recommendations.

David H Howard1.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22826149     DOI: 10.1001/archinternmed.2012.2768

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  11 in total

1.  The cost implications of prostate cancer screening in the Medicare population.

Authors:  Xiaomei Ma; Rong Wang; Jessica B Long; Joseph S Ross; Pamela R Soulos; James B Yu; Danil V Makarov; Heather T Gold; Cary P Gross
Journal:  Cancer       Date:  2013-10-04       Impact factor: 6.860

Review 2.  Multicriteria decision analysis in oncology.

Authors:  Georges Adunlin; Vakaramoko Diaby; Alberto J Montero; Hong Xiao
Journal:  Health Expect       Date:  2014-03-17       Impact factor: 3.377

3.  Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014.

Authors:  Jun Li; David A Siegel; Jessica B King
Journal:  Ann Epidemiol       Date:  2018-03-06       Impact factor: 3.797

4.  Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation.

Authors:  David H Howard; Florence K Tangka; Gery P Guy; Donatus U Ekwueme; Joseph Lipscomb
Journal:  Health Aff (Millwood)       Date:  2013-03       Impact factor: 6.301

5.  Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis.

Authors:  Sigrid V Carlsson; Tiago M de Carvalho; Monique J Roobol; Jonas Hugosson; Anssi Auvinen; Maciej Kwiatkowski; Arnauld Villers; Marco Zappa; Vera Nelen; Alvaro Páez; James A Eastham; Hans Lilja; Harry J de Koning; Andrew J Vickers; Eveline A M Heijnsdijk
Journal:  Cancer       Date:  2016-07-26       Impact factor: 6.860

6.  PSA screening for prostate cancer: why so much controversy?

Authors:  Fernand Labrie
Journal:  Asian J Androl       Date:  2013-06-17       Impact factor: 3.285

7.  Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.

Authors:  Brenda K Edwards; Anne-Michelle Noone; Angela B Mariotto; Edgar P Simard; Francis P Boscoe; S Jane Henley; Ahmedin Jemal; Hyunsoon Cho; Robert N Anderson; Betsy A Kohler; Christie R Eheman; Elizabeth M Ward
Journal:  Cancer       Date:  2013-12-16       Impact factor: 6.860

8.  Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score.

Authors:  Kimberly A Herget; Darshan P Patel; Heidi A Hanson; Carol Sweeney; William T Lowrance
Journal:  Cancer Med       Date:  2015-12-02       Impact factor: 4.452

9.  The number of key carcinogenic events can be predicted from cancer incidence.

Authors:  Aleksey V Belikov
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

10.  Time trends in prostate cancer screening in Swiss primary care (2010 to 2017) - A retrospective study.

Authors:  Stefan Zechmann; Stefania Di Gangi; Vladimir Kaplan; Rahel Meier; Thomas Rosemann; Fabio Valeri; Oliver Senn
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.